Healthcare & Life Sciences Private Equity Deal Tracker: Linden Capital Acquires BioIVT From Arsenal Capital

McGuireWoods LLP
Contact

Linden Capital Partners has announced it has acquired BioIVT from Arsenal Capital Partners.

BioIVT, based in, Westbury, N.Y., is a provider of biological specimens for the pharmaceutical discovery and development market. Formerly BioreclamationIVT, the company specializes in control and disease state samples, including human and animal tissues, cell products, blood and other biofluids.

Linden, based in Chicago, is a private equity firm focused exclusively on the healthcare industry. Founded in 2004, the firm pursues acquisition opportunities across the healthcare industry, including services, products and distribution companies, and prefers to make more substantial investments from a dollars perspective.

Arsenal, based in New York, is a private equity firm specializing in investments in middle market healthcare and specialty industrials companies. Founded in 2000, the firm seeks control investments in companies with the capacity to use $50 million to $300 million of equity, including add-on acquisitions.

Terms of the transaction were not disclosed.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McGuireWoods LLP | Attorney Advertising

Written by:

McGuireWoods LLP
Contact
more
less

McGuireWoods LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.